Publications by authors named "Albert Fournier"

Claim this Profile
E
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.
Aurélie Lenglet, Sophie Liabeuf, Najeh El Esper, Sandrine Brisset, Janette Mansour, Albert Fournier

Nephrol Dial Transplant· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.
Aurélie Lenglet, Sophie Liabeuf, Najeh El Esper, Sandrine Brisset, Janette Mansour, Albert Fournier

Nephrol Dial Transplant· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association between 25-Hydroxyvitamin D and Hemoglobin A1c Levels in Patients with Type 2 Diabetes and Stage 1-5 Chronic Kidney Disease.
Farshad Kajbaf, Romuald Mentaverri, Momar Diouf, Albert Fournier, Said Kamel

Int J Endocrinol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of nicotinamide to treat hyperphosphatemia in dialysis patients.
Aurélie Lenglet, Sophie Liabeuf, Pauline Guffroy, Albert Fournier, Michel Brazier

Drugs R D· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between angiotensin receptor blockers and better cognitive outcome: urgent need for a randomized trial.
Roxana Oprisiu, Albert Fournier, Jean Michel Achard, Sandra E Black, Jean-Marie Serot

JAMA Neurol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythrocyte metformin levels in patients with type 2 diabetes and varying severity of chronic kidney disease.
Claire Briet, Marie Saraval-Gross, Farshad Kajbaf, Albert Fournier, Lionel Hary

Clin Kidney J· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious spontaneous epistaxis and hypertension in hospitalized patients.
Cyril Page, Aurélie Biet, Sophie Liabeuf, Vladimir Strunski, Albert Fournier

Eur Arch Otorhinolaryngol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
Roxana Oprisiu-Fournier, Sébastien Faure, Hakim Mazouz, Florent Boutitie, Jean-Marie Serot, Albert Fournier

Expert Rev Neurother· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Albert Fournier, Roxana Oprisiu-Fournier, Jean-Marie Serot, Olivier Godefroy, Jean-Michel Achard

Expert Rev Neurother· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D affects survival independently of vascular calcification in chronic kidney disease.
Daniela Veit Barreto, Fellype Carvalho Barreto, Sophie Liabeuf, Mohammed Temmar, Francis Boitte, Albert Fournier

Clin J Am Soc Nephrol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
About the association between high alkaline phosphatase and risk of death and hospitalization in dialysis patients.
Amal Baakrim, Irina Shahapuni, Mervet Rouached, Albert Fournier

Kidney Int· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telmisartan for prevention of cardiovascular events.
Roxana Oprisiu Fournier, Jean-Michel Achard, Albert Fournier

N Engl J Med· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors.
Sebastien Faure, Annabelle Bureau, Nicole Oudart, James Javellaud, Albert Fournier

J Hypertens· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihypertensive treatment and stroke prevention in patients with and without chronic kidney disease: a review of controlled trials.
Liviu Segall, Roxana Oprisiu, Albert Fournier, Adrian Covic

J Nephrol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
Mervet Rouached, Sarra El Kadiri Boutchich, Assem Mohamed Al Rifai, Michèle Garabédian, Albert Fournier

Kidney Int· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D levels and early mortality among incident hemodialysis patients.
Sébastien Mailliez, Irina Shahapuni, Caroline Lecaque, Ziad A Massy, Gabriel Choukroun, Albert Fournier

Kidney Int· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis.
Irina Shahapuni, Najeh E L Esper, Roxana Opisiv, Ziad Massy, Gabriel Choukroun, Albert Fournier

Nephrol Dial Transplant· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JIKEI trial.
Florent Boutitie, François Gueyffier, Jean-Michel Achard, Mohamed Temmar, Albert Fournier

Lancet· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diuretic-based therapy].
Claire Presne, Matthieu Monge, Janette Mansour, Roxana Oprisiu, Gabriel Choukroun, Albert Fournier

Nephrol Ther· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II.
Florent Boutitie, Roxana Oprisiu, Jean Michel Achard, Hakim Mazouz, Jiguang Wang, Albert Fournier

J Hypertens· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation.
Matthieu Monge, Nelly Ledemé, Hakim Mazouz, Jean-Daniel Lalau, Mona Moubarak, Albert Fournier

Nephrol Dial Transplant· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Which optimal antihypertensive bitherapy for kidney patients?].
Jean-François Bonne, Irina Shahapuni, Sébastien Mailliez, Roxana Oprisiu, Mohamed Temmar, Albert Fournier

Nephrol Ther· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal paricalcitol starting dose for parathyroid hormone suppression in secondary hyperparathyroidism.
Jeannette Mansour, Irina Shahapuni, Sébastien Mailliez, Rachid Aghai, Albert Fournier

Nat Clin Pract Nephrol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of calcium and vitamin D therapy on arterial and cardiac disease in young adults with childhood-onset end stage renal disease.
Albert Fournier, Laid Harbouche, Jeanette Mansour, Irina Shahapuni

Nephrol Dial Transplant· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating stroke in the 21st century.
Roxana Oprisiu, Jean-Marie Serot, Sandra E Black, Jean-Michel Achard, Albert Fournier

Lancet· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis